Vanguard Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7B | Buy |
23,973,777
+482,616
| +2% | +$215M | 0.17% | 98 |
|
|
2025
Q1 | $11.4B | Buy |
23,491,161
+232,873
| +1% | +$113M | 0.21% | 84 |
|
|
2024
Q4 | $9.37B | Buy |
23,258,288
+98,654
| +0.4% | +$39.7M | 0.16% | 100 |
|
|
2024
Q3 | $10.8B | Buy |
23,159,634
+184,113
| +0.8% | +$85.6M | 0.19% | 86 |
|
|
2024
Q2 | $10.8B | Buy |
22,975,521
+299,003
| +1% | +$140M | 0.21% | 81 |
|
|
2024
Q1 | $9.48B | Buy |
22,676,518
+394,338
| +2% | +$165M | 0.19% | 93 |
|
|
2023
Q4 | $9.07B | Buy |
22,282,180
+298,824
| +1% | +$122M | 0.2% | 87 |
|
|
2023
Q3 | $7.64B | Buy |
21,983,356
+87,397
| +0.4% | +$30.4M | 0.19% | 92 |
|
|
2023
Q2 | $7.71B | Buy |
21,895,959
+49,807
| +0.2% | +$17.5M | 0.18% | 92 |
|
|
2023
Q1 | $6.88B | Buy |
21,846,152
+299,249
| +1% | +$94.3M | 0.18% | 101 |
|
|
2022
Q4 | $6.22B | Buy |
21,546,903
+414,567
| +2% | +$120M | 0.17% | 111 |
|
|
2022
Q3 | $6.12B | Buy |
21,132,336
+293,861
| +1% | +$85.1M | 0.18% | 95 |
|
|
2022
Q2 | $5.87B | Buy |
20,838,475
+365,004
| +2% | +$103M | 0.17% | 106 |
|
|
2022
Q1 | $5.34B | Buy |
20,473,471
+317,629
| +2% | +$82.9M | 0.13% | 139 |
|
|
2021
Q4 | $4.43B | Sell |
20,155,842
-286,849
| -1% | -$63M | 0.1% | 185 |
|
|
2021
Q3 | $3.71B | Buy |
20,442,691
+193,473
| +1% | +$35.1M | 0.09% | 205 |
|
|
2021
Q2 | $4.08B | Sell |
20,249,218
-166,493
| -0.8% | -$33.6M | 0.1% | 180 |
|
|
2021
Q1 | $4.39B | Sell |
20,415,711
-17,339
| -0.1% | -$3.73M | 0.12% | 145 |
|
|
2020
Q4 | $4.83B | Sell |
20,433,050
-256,869
| -1% | -$60.7M | 0.14% | 128 |
|
|
2020
Q3 | $5.63B | Sell |
20,689,919
-183,238
| -0.9% | -$49.9M | 0.19% | 91 |
|
|
2020
Q2 | $6.06B | Buy |
20,873,157
+264,218
| +1% | +$76.7M | 0.21% | 78 |
|
|
2020
Q1 | $4.9B | Buy |
20,608,939
+514,705
| +3% | +$122M | 0.21% | 90 |
|
|
2019
Q4 | $4.4B | Buy |
20,094,234
+166,055
| +0.8% | +$36.4M | 0.15% | 118 |
|
|
2019
Q3 | $3.38B | Buy |
19,928,179
+266,379
| +1% | +$45.1M | 0.13% | 163 |
|
|
2019
Q2 | $3.61B | Buy |
19,661,800
+180,239
| +0.9% | +$33.1M | 0.14% | 138 |
|
|
2019
Q1 | $3.58B | Buy |
19,481,561
+92,370
| +0.5% | +$17M | 0.14% | 131 |
|
|
2018
Q4 | $3.21B | Buy |
19,389,191
+613,939
| +3% | +$102M | 0.14% | 129 |
|
|
2018
Q3 | $3.62B | Buy |
18,775,252
+213,550
| +1% | +$41.2M | 0.14% | 127 |
|
|
2018
Q2 | $3.15B | Buy |
18,561,702
+223,136
| +1% | +$37.9M | 0.13% | 134 |
|
|
2018
Q1 | $2.99B | Buy |
18,338,566
+404,062
| +2% | +$65.9M | 0.13% | 141 |
|
|
2017
Q4 | $2.69B | Buy |
17,934,504
+322,457
| +2% | +$48.3M | 0.12% | 169 |
|
|
2017
Q3 | $2.68B | Buy |
17,612,047
+632,175
| +4% | +$96.1M | 0.13% | 154 |
|
|
2017
Q2 | $2.19B | Buy |
16,979,872
+504,982
| +3% | +$65.1M | 0.11% | 187 |
|
|
2017
Q1 | $1.8B | Buy |
16,474,890
+560,796
| +4% | +$61.3M | 0.09% | 227 |
|
|
2016
Q4 | $1.17B | Buy |
15,914,094
+312,003
| +2% | +$23M | 0.07% | 338 |
|
|
2016
Q3 | $1.36B | Buy |
15,602,091
+336,916
| +2% | +$29.4M | 0.08% | 273 |
|
|
2016
Q2 | $1.31B | Buy |
15,265,175
+329,337
| +2% | +$28.3M | 0.08% | 261 |
|
|
2016
Q1 | $1.19B | Buy |
14,935,838
+432,369
| +3% | +$34.4M | 0.08% | 280 |
|
|
2015
Q4 | $1.82B | Buy |
14,503,469
+401,421
| +3% | +$50.5M | 0.12% | 156 |
|
|
2015
Q3 | $1.47B | Buy |
14,102,048
+256,109
| +2% | +$26.7M | 0.11% | 191 |
|
|
2015
Q2 | $1.71B | Buy |
13,845,939
+328,820
| +2% | +$40.6M | 0.12% | 171 |
|
|
2015
Q1 | $1.59B | Sell |
13,517,119
-1,984,568
| -13% | -$234M | 0.11% | 192 |
|
|
2014
Q4 | $1.84B | Sell |
15,501,687
-1,734,646
| -10% | -$206M | 0.13% | 148 |
|
|
2014
Q3 | $1.94B | Buy |
17,236,333
+533,587
| +3% | +$59.9M | 0.15% | 130 |
|
|
2014
Q2 | $1.58B | Buy |
16,702,746
+314,096
| +2% | +$29.7M | 0.12% | 160 |
|
|
2014
Q1 | $1.16B | Buy |
16,388,650
+656,739
| +4% | +$46.4M | 0.1% | 216 |
|
|
2013
Q4 | $1.17B | Buy |
15,731,911
+322,023
| +2% | +$23.9M | 0.1% | 202 |
|
|
2013
Q3 | $1.17B | Buy |
15,409,888
+3,842,902
| +33% | +$291M | 0.11% | 168 |
|
|
2013
Q2 | $924M | Buy |
+11,566,986
| New | +$924M | 0.1% | 210 |
|